Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BMI - US0565251081 - Common Stock

176.39 USD
+1.98 (+1.14%)
Last: 1/2/2026, 8:04:00 PM
176.39 USD
0 (0%)
After Hours: 1/2/2026, 8:04:00 PM
Fundamental Rating

7

Overall BMI gets a fundamental rating of 7 out of 10. We evaluated BMI against 124 industry peers in the Electronic Equipment, Instruments & Components industry. BMI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BMI is valied quite expensively at the moment, while it does show a decent growth rate. This makes BMI very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

BMI had positive earnings in the past year.
In the past year BMI had a positive cash flow from operations.
BMI had positive earnings in each of the past 5 years.
Each year in the past 5 years BMI had a positive operating cash flow.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

BMI has a Return On Assets of 14.19%. This is amongst the best in the industry. BMI outperforms 94.35% of its industry peers.
Looking at the Return On Equity, with a value of 19.75%, BMI belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
BMI has a Return On Invested Capital of 16.43%. This is amongst the best in the industry. BMI outperforms 93.55% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BMI is significantly above the industry average of 9.00%.
The 3 year average ROIC (15.23%) for BMI is below the current ROIC(16.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROIC 16.43%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of BMI (15.40%) is better than 93.55% of its industry peers.
In the last couple of years the Profit Margin of BMI has grown nicely.
BMI has a Operating Margin of 19.93%. This is amongst the best in the industry. BMI outperforms 97.58% of its industry peers.
BMI's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 41.26%, BMI is doing good in the industry, outperforming 70.16% of the companies in the same industry.
BMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BMI is still creating some value.
BMI has more shares outstanding than it did 1 year ago.
BMI has more shares outstanding than it did 5 years ago.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BMI has an Altman-Z score of 14.02. This indicates that BMI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 14.02, BMI belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.02
ROIC/WACC1.73
WACC9.48%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BMI has a Current Ratio of 3.22. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI's Current ratio of 3.22 is fine compared to the rest of the industry. BMI outperforms 66.13% of its industry peers.
A Quick Ratio of 2.23 indicates that BMI has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.23, BMI is doing good in the industry, outperforming 62.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.23
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

BMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.63%, which is quite good.
Measured over the past years, BMI shows a very strong growth in Earnings Per Share. The EPS has been growing by 21.16% on average per year.
Looking at the last year, BMI shows a quite strong growth in Revenue. The Revenue has grown by 12.11% in the last year.
BMI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.25% yearly.
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.65% yearly.
The Revenue is expected to grow by 9.05% on average over the next years. This is quite good.
EPS Next Y14.83%
EPS Next 2Y13.74%
EPS Next 3Y11.42%
EPS Next 5Y11.65%
Revenue Next Year12.55%
Revenue Next 2Y10.45%
Revenue Next 3Y8.95%
Revenue Next 5Y9.05%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 37.53, the valuation of BMI can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as BMI.
BMI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.60.
A Price/Forward Earnings ratio of 32.24 indicates a quite expensive valuation of BMI.
BMI's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, BMI is valued a bit more expensive.
Industry RankSector Rank
PE 37.53
Fwd PE 32.24
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BMI's Enterprise Value to EBITDA ratio is in line with the industry average.
BMI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BMI is cheaper than 67.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 31.26
EV/EBITDA 23.14
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMI does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of BMI may justify a higher PE ratio.
PEG (NY)2.53
PEG (5Y)1.77
EPS Next 2Y13.74%
EPS Next 3Y11.42%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.88%, BMI is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.47, BMI pays a better dividend. On top of this BMI pays more dividend than 84.68% of the companies listed in the same industry.
With a Dividend Yield of 0.88, BMI pays less dividend than the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

On average, the dividend of BMI grows each year by 13.80%, which is quite nice.
BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
BMI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.8%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

30.10% of the earnings are spent on dividend by BMI. This is a low number and sustainable payout ratio.
BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.1%
EPS Next 2Y13.74%
EPS Next 3Y11.42%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (1/2/2026, 8:04:00 PM)

After market: 176.39 0 (0%)

176.39

+1.98 (+1.14%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners101.99%
Inst Owner Change1.91%
Ins Owners0.51%
Ins Owner Change0%
Market Cap5.20B
Revenue(TTM)901.14M
Net Income(TTM)138.78M
Analysts76
Price Target222.59 (26.19%)
Short Float %7.66%
Short Ratio7.37
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.22
Dividend Growth(5Y)13.8%
DP30.1%
Div Incr Years18
Div Non Decr Years18
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.02%
Min EPS beat(2)-7.6%
Max EPS beat(2)3.55%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)5
Avg EPS beat(8)4.65%
EPS beat(12)8
Avg EPS beat(12)6.34%
EPS beat(16)11
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.62%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)0.62%
Revenue beat(8)4
Avg Revenue beat(8)1.08%
Revenue beat(12)8
Avg Revenue beat(12)2.82%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)-1.31%
PT rev (3m)-6.18%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)1.3%
EPS NY rev (1m)-0.11%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 37.53
Fwd PE 32.24
P/S 5.77
P/FCF 31.26
P/OCF 28.73
P/B 7.4
P/tB 15.12
EV/EBITDA 23.14
EPS(TTM)4.7
EY2.66%
EPS(NY)5.47
Fwd EY3.1%
FCF(TTM)5.64
FCFY3.2%
OCF(TTM)6.14
OCFY3.48%
SpS30.58
BVpS23.84
TBVpS11.67
PEG (NY)2.53
PEG (5Y)1.77
Graham Number50.21
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROCE 21.77%
ROIC 16.43%
ROICexc 21.75%
ROICexgc 51.26%
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
FCFM 18.45%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
ROICexc(3y)23.61%
ROICexc(5y)20.43%
ROICexgc(3y)41.01%
ROICexgc(5y)36.17%
ROCE(3y)20.17%
ROCE(5y)18.85%
ROICexgc growth 3Y15.78%
ROICexgc growth 5Y16.08%
ROICexc growth 3Y21.65%
ROICexc growth 5Y15.12%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.31%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 84.78%
Profit Quality 119.84%
Current Ratio 3.22
Quick Ratio 2.23
Altman-Z 14.02
F-Score5
WACC9.48%
ROIC/WACC1.73
Cap/Depr(3y)34.99%
Cap/Depr(5y)33.03%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.55%
Profit Quality(3y)111.64%
Profit Quality(5y)126.18%
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
EPS Next Y14.83%
EPS Next 2Y13.74%
EPS Next 3Y11.42%
EPS Next 5Y11.65%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%
Revenue Next Year12.55%
Revenue Next 2Y10.45%
Revenue Next 3Y8.95%
Revenue Next 5Y9.05%
EBIT growth 1Y19.1%
EBIT growth 3Y26.12%
EBIT growth 5Y20.53%
EBIT Next Year39.7%
EBIT Next 3Y17.64%
EBIT Next 5Y15.08%
FCF growth 1Y83.29%
FCF growth 3Y20.76%
FCF growth 5Y14.2%
OCF growth 1Y77.62%
OCF growth 3Y21%
OCF growth 5Y13.95%

BADGER METER INC / BMI FAQ

What is the fundamental rating for BMI stock?

ChartMill assigns a fundamental rating of 7 / 10 to BMI.


Can you provide the valuation status for BADGER METER INC?

ChartMill assigns a valuation rating of 3 / 10 to BADGER METER INC (BMI). This can be considered as Overvalued.


Can you provide the profitability details for BADGER METER INC?

BADGER METER INC (BMI) has a profitability rating of 9 / 10.


Can you provide the expected EPS growth for BMI stock?

The Earnings per Share (EPS) of BADGER METER INC (BMI) is expected to grow by 14.83% in the next year.


How sustainable is the dividend of BADGER METER INC (BMI) stock?

The dividend rating of BADGER METER INC (BMI) is 6 / 10 and the dividend payout ratio is 30.1%.